[Inhibition of immune cytotoxic lymphocyte induction by antilymphocyte autoantibodies from the blood serum of patients with preleukemia and leukemia]

Autor: A F, Etkin, M M, Gurevich

Publikováno v: Eksperimental'naia onkologiia. 12(4)

The influence of the presence of antilymphocyte IgG autoantibodies (ALA) from sera of haematologic patients and human retrovirus-infected ones was studied by determination of the cytotoxic lymphocyte (CTL) activity in mixed lymphocyte culture (MLC).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::44938c34ec55d81fc63a2e945c760a3d
https://pubmed.ncbi.nlm.nih.gov/2143134

[Characteristics of lymphocyte autoantigens]

Autor: A F, Etkin, M M, Gurevich

Publikováno v: Gematologiia i transfuziologiia. 34(3)

Specificity of autoantibodies against lymphocyte antigens was assayed in sera of patients with autoimmune hematologic diseases, leukemias, secondary immunodeficiencies as well as in sera of persons seropositive to antibodies against retroviruses HTLV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a9bd90f67a8ccd771cd978d1b61b1885
https://pubmed.ncbi.nlm.nih.gov/2566553

Detection and analysis of antibodies against retrovirus determinants in the sera of haematologic patients

Autor: A F, Etkin, S V, Litvinov, M M, Gurevich

Publikováno v: Acta virologica. 33(2)

A panel of 11 retroviruses including animal retroviruses types B, C, D and human retroviruses HTLV-I and HTLV-III was used as antigen for detection of antibodies in 265 sera of patients suffering from haematologic and autoimmune diseases and in 98 co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2fb51e94f70c394bc55d226a758f7354
https://pubmed.ncbi.nlm.nih.gov/2569811

Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case - control analysis.

Autor: Miron G; Multiple Sclerosis Center, Sheba Medical Center, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Gurevich M; Multiple Sclerosis Center, Sheba Medical Center, Ramat Gan, Israel., Baum S; Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel., Achiron A; Multiple Sclerosis Center, Sheba Medical Center, Ramat Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Barzilai A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2017 Dec; Vol. 31 (12), pp. 2055-2061. Date of Electronic Publication: 2017 Jul 17.

RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis.

Autor: Achiron A; Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Sackler School of Medicine, Tel-Aviv University, Israel., Zilkha-Falb R; Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel., Mashiach R; Department of Chemistry, Ben-Gurion University of the Negev, Be'er-Sheva, Israel., Gurevich M; Multiple Sclerosis Center, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel. Electronic address: gurevich@sheba.health.gov.il.

Publikováno v: Journal of neuroimmunology [J Neuroimmunol] 2017 Jan 15; Vol. 302, pp. 41-48. Date of Electronic Publication: 2016 Nov 17.